These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25332821)

  • 1. Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing.
    Granada JF; Stenoien M; Buszman PP; Tellez A; Langanki D; Kaluza GL; Leon MB; Gray W; Jaff MR; Schwartz RS
    Open Heart; 2014; 1(1):e000117. PubMed ID: 25332821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model.
    Li Y; Tellez A; Rousselle SD; Dillon KN; Garza JA; Barry C; Granada JF
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine.
    Buszman PP; Milewski K; Zurakowski A; Pajak J; Jelonek M; Gasior P; Peppas A; Tellez A; Granada JF; Buszman PE
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):325-33. PubMed ID: 23703720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.
    Buszman PP; Tellez A; Afari ME; Peppas A; Conditt GB; Rousselle SD; McGregor JC; Stenoien M; Kaluza GL; Granada JF
    JACC Cardiovasc Interv; 2013 Aug; 6(8):883-90. PubMed ID: 23968706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Paclitaxel Dose on Tissue Pharmacokinetics and Vascular Healing: A Comparative Drug-Coated Balloon Study in the Familial Hypercholesterolemic Swine Model of Superficial Femoral In-Stent Restenosis.
    Gongora CA; Shibuya M; Wessler JD; McGregor J; Tellez A; Cheng Y; Conditt GB; Kaluza GL; Granada JF
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1115-1123. PubMed ID: 26117470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.
    Buszman PP; Tellez A; Afari M; Cheng Y; Conditt GB; McGregor JC; Milewski K; Stenoien M; Kaluza GL; Granada JF
    EuroIntervention; 2013 Aug; 9(4):510-6. PubMed ID: 23965356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients.
    Tzafriri AR; Muraj B; Garcia-Polite F; Salazar-Martín AG; Markham P; Zani B; Spognardi A; Albaghdadi M; Alston S; Edelman ER
    Biomaterials; 2020 Nov; 260():120337. PubMed ID: 32937269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Fluoropolymer-Based Paclitaxel Delivery on Neointimal Proliferation and Vascular Healing: A Comparative Peripheral Drug-Eluting Stent Study in the Familial Hypercholesterolemic Swine Model of Femoral Restenosis.
    Gasior P; Cheng Y; Valencia AF; McGregor J; Conditt GB; Kaluza GL; Granada JF
    Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28487355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological effect on restenosis and vascular healing of encapsulated paclitaxel nanocrystals delivered via coated balloon technology in the familial hypercholesterolaemic swine model of in-stent restenosis.
    Cheng Y; Shibuya M; McGregor J; Conditt GB; Yi GH; Kaluza GL; Gray W; Doshi M; Sojitra P; Granada JF
    EuroIntervention; 2016 Oct; 12(9):1164-1173. PubMed ID: 27753601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects on vascular healing of bare metal stents delivered via paclitaxel-coated balloons in the porcine model of restenosis.
    Cremers B; Milewski K; Clever YP; Aboodi MS; Biedermann M; Thim T; Kelsch B; Kaluza GL; Scheller B; Granada JF
    Catheter Cardiovasc Interv; 2012 Oct; 80(4):603-10. PubMed ID: 22511557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters.
    Speck U; Häckel A; Schellenberger E; Kamann S; Löchel M; Clever YP; Peters D; Scheller B; Trog S; Bettink S
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1599-1610. PubMed ID: 29968090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.
    Milewski K; Tellez A; Aboodi MS; Conditt GB; Yi GH; Thim T; Stenoien M; McGregor JC; Gray WA; Virmani R; Granada JF; Kaluza GL
    EuroIntervention; 2011 Jul; 7(3):362-8. PubMed ID: 21729839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloons for coronary and peripheral interventional procedures.
    Wöhrle J
    Curr Cardiol Rep; 2012 Oct; 14(5):635-41. PubMed ID: 22825918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of different paclitaxel-eluting balloons in a porcine model.
    Pérez de Prado A; Pérez-Martínez C; Cuellas Ramón C; Regueiro Purriños M; Diego Nieto A; Gonzalo-Orden JM; Molina Crisol M; Gómez Castel A; Duocastella Codina L; Fernández-Vázquez F
    Rev Esp Cardiol (Engl Ed); 2014 Jun; 67(6):456-62. PubMed ID: 24863594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Sirolimus-Coated Balloon Catheter: In Vivo Evaluation in a Porcine Coronary Model.
    Clever YP; Peters D; Calisse J; Bettink S; Berg MC; Sperling C; Stoever M; Cremers B; Kelsch B; Böhm M; Speck U; Scheller B
    Circ Cardiovasc Interv; 2016 Apr; 9(4):e003543. PubMed ID: 27069105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effect of orbital atherectomy and adjunctive paclitaxel-coated balloon therapy on vascular healing and drug retention: early experimental insights into the familial hypercholesterolaemic swine model of femoral artery stenosis.
    Tellez A; Dattilo R; Mustapha JA; Gongora CA; Hyon CM; Palmieri T; Rousselle S; Kaluza GL; Granada JF
    EuroIntervention; 2014 Dec; 10(8):1002-8. PubMed ID: 25308298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local drug delivery - the early Berlin experience: single drug administration versus sustained release.
    Speck U; Scheller B; Rutsch W; Laule M; Stangl V
    EuroIntervention; 2011 May; 7 Suppl K():K17-22. PubMed ID: 22027723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel biodegradable polymer-coated, paclitaxel-eluting stent inhibits neointimal formation in porcine coronary arteries.
    Buszman P; Milewski K; Zurakowski A; Pajak J; Liszka Ł; Buszman P; Musioł E; AbuSamra M; Trznadel S; Kałuza G
    Kardiol Pol; 2010 May; 68(5):503-9. PubMed ID: 20491008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative vascular responses three months after paclitaxel and everolimus-eluting stent implantation in streptozotocin-induced diabetic porcine coronary arteries.
    Sheehy A; Hsu S; Bouchard A; Lema P; Savard C; Guy LG; Tai J; Polyakov I
    Cardiovasc Diabetol; 2012 Jun; 11():75. PubMed ID: 22716997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries.
    Speck U; Scheller B; Abramjuk C; Breitwieser C; Dobberstein J; Boehm M; Hamm B
    Radiology; 2006 Aug; 240(2):411-8. PubMed ID: 16864669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.